Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Affiliations

• ¹ Hematology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
• ² Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
• ³ Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France.
• ⁴ Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212, Paris, France.
• ⁵ Pediatric Onco-hematology Department, Montpellier Hospital, Montpellier, France.
• ⁶ Hematology Department, Avicenne Hospital, AP-HP, Paris, France.
• ⁷ Hematology Laboratory, Trousseau Hospital, AP-HP, Paris, France.
• ⁸ Hematology Laboratory, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
• ⁹ Hematology Department, Angers University Hospital, Angers, France.
• ¹⁰ Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), INSERM 1232, Nantes, France.
• ¹¹ Fédération Hospitalo-Universitaire Grand Ouest Against Leukemia (FHU GOAL), Angers, France.
• ¹² Hematology Department, Cochin Hospital, AP-HP, Paris, France.
• ¹³ Hematology Department, Henri Mondor Hospital, AP-HP, Créteil, France.
• ¹⁴ Pediatric Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
• ¹⁵ Hematology Department, Reims University Hospital, Reims, France.
• ¹⁶ Hematology Department, Côte Basque Hospital, Bayonne, France.
• ¹⁷ Hematology Department, Nantes University Hospital, Nantes, France.
• ¹⁸ Hematology Department, Versailles André Mignot Hospital, University Paris-Saclay, Le Chesnay, France.
• ¹⁹ Department of Genetics and.
• ²⁰ Pediatric Onco-hematology Department, Robert Debré Hospital, AP-HP, Paris, France.
• ²¹ EA-3518, Saint-Louis Research Institute, Université de Paris, Paris, France; and.
• ²² Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, AP-HP, Paris, France.